glp 1 pill novo nordisk More than 170,000 people in U.S. are taking Wegovy pill, says Novo Nordisk's GLP-1 weight-loss pill

Mechanism of Action Metformin decreases hepatic glucose production and improves hepatic insulin sensitivity but has only a modest impact on peripheral insulin-mediated glucose uptake (i.e., insulin resistance), which is likely due to a reduction in hyperglycemia, triglycerides, and free fatty acid levels (48,49)

Important safety considerations include: Increased hypoglycaemia risk when used with insulin or sulfonylureas (dose adjustments of these medications may be needed) Potential worsening of diabetic retinopathy with rapid improvement in blood glucose control, particularly with semaglutide Need for monitoring in patients with pre-existing retinopathy The MHRA continues to monitor the safety profile of these agents

Despite its important function, the gallbladder is not essential for survival, and problems such as gallstones or inflammation can lead to the need for its removal

doi: 10.1002/art.10520 136 FavaRAOlsenNJSpencer-GreenGYeoKTYeoTKBerseBet al